首页> 外文期刊>Veterinarni medicina >Dynamics of milk leukocytes in response to intramammary infusion of amoxicillin plus sulbactam during bovine subclinical mastitis
【24h】

Dynamics of milk leukocytes in response to intramammary infusion of amoxicillin plus sulbactam during bovine subclinical mastitis

机译:牛亚临床乳腺炎期间阿莫西林加舒巴坦乳腺内输注对牛奶白细胞的动态影响

获取原文
获取外文期刊封面目录资料

摘要

The therapeutic potential of amoxicillin plus sulbactam and its effect on dynamics of milk leukocytes in bovine sub clinical mastitis were investigated in this study. Therapeutic efficacy was measured by somatic cell count and total bacterial count of the milk, whereas, the dynamics of milk leukocytes were assessed by measuring phagocytosis, hydrogen peroxide production, myeloperoxidase and lactoperoxidase enzyme levels in the milk leu-kocytes. Forty-five crossbred cows were randomly divided into three equal groups. Group I consisting of 15.cows served as healthy control, whereas 30 cows (sub clinical mastitis) were randomly divided into Groups II and III on the basis of positive reactions in the California Mastitis Test. Group II cows received 300mg of amoxicillin plus sulbactam twice daily for three days and Group III received sterile 5 ml phosphate buffer saline (pH 7.4) for three days. Both treatments were administered via the intramammary route. Observations were made up to 15.days after initiation of treatment. The results revealed a pronounced drop in somatic cell count and total bacterial count, whereas significant (P < 0.05) enhancement of phagocytic activity (42.20%), hydrogen peroxide produc-tion (29.46%), myeloperoxidase (49.27%) and lactoperoxidase (147.10%) enzyme levels in the milk leukocytes in Group II cows during post treatment periods were observed. Such changes were statistically non-significant in Group III cows. The results of the present study indicate that intramammary use of amoxicillin plus sulbactam augments the bactericidal function of milk leukocytes during bovine sub clinical mastitis and demonstrate the strong therapeutic potential against bovine subclinical mastitis
机译:本研究探讨了阿莫西林加舒巴坦在牛亚临床性乳腺炎中的治疗潜力及其对乳白细胞动力学的影响。通过乳的体细胞计数和总细菌计数来测量治疗功效,而通过测量乳白细胞中的吞噬作用,过氧化氢产生,髓过氧化物酶和乳过氧化物酶水平来评估乳白细胞的动力学。将四十五头杂种母牛随机分为三组。 I组由15头母牛组成,作为健康对照组,而30头母牛(亚临床性乳腺炎)根据加利福尼亚乳腺炎测试中的阳性反应随机分为II组和III组。第二组母牛每天两次接受300mg阿莫西林加舒巴坦的治疗,持续三天,第三组母牛接受无菌的5ml磷酸盐缓冲液(pH 7.4)治疗三天。两种治疗均通过乳内途径进行。在开始治疗后长达15天进行观察。结果表明,体细胞数和总细菌数明显下降,而吞噬活性(42.20%),过氧化氢生产(29.46%),髓过氧化物酶(49.27%)和乳过氧化物酶(147.10)显着(P <0.05)增强。在治疗后观察到第二组奶牛的乳白细胞中的%酶水平。在第三组奶牛中,这种变化在统计学上不显着。本研究的结果表明,阿莫西林加舒巴坦的乳内使用可增强牛亚临床乳腺炎期间乳白细胞的杀菌功能,并显示出对牛亚临床乳腺炎的强大治疗潜力

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号